GENE ONLINE|News &
Opinion
Blog

Gilead Sciences
Amgen’s KRAS G12C Inhibitor Impresses in Phase 2 NSCLC Trial
2020-10-09
ViiV Healthcare’s Two Drug Regimen Shows Promising Results in HIV-1 Patients
2020-10-06
EU Commission Grants Marketing Authorization for Gilead’s Rheumatoid Arthritis Treatment
2020-10-04
Gilead Strengthens its Oncology Portfolio with Acquisition of Immunomedics
2020-09-14
Gilead Adds Jounce to its Long List of Oncology Partnerships
2020-09-03
First and Only CAR T Therapy for Mantle Cell Lymphoma Gets FDA Nod
2020-07-30
BIO Digital 2020 Highlights: Challenges in Bringing New Cell and Gene Therapies to Market
2020-06-23
Dexamethasone Renews Hopes for a Life Saving COVID-19 Treatment
2020-06-20
Remdesivir Registers Middling Benefit in Patients with Moderate COVID-19
2020-06-01
Long-Acting Cabotegravir Injection Performs Better as an HIV PrEP than Daily Pills
2020-05-22
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
COVID-19: Gilead’s Promising Remdesivir Data Jumps US Stocks, Hastens FDA’s Emergency Authorization Plans
2020-04-29
Gilead, Kite, and oNKo-innate Collaborate to Advance Cancer Immunotherapy Using NK Cells
2020-04-26
Remdesivir’s Early Trial Data Necessitates Guarded Optimism
2020-04-12
R&D
Gilead, Second Genome Partner to Explore Microbial Biomarkers
2020-04-08
1 2 3 4 5
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!